ArticleJHLT open2026
Trends, center level practice, and outcomes of heart transplantation in people with HIV.
Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Background: Kidney and liver transplantation have become standard of care for medically eligible people with HIV (PWH) with end-organ disease in the US, but data on heart transplantation (HT) in PWH remains limited. Methods: We used US national registry data 2014-2024 to identify 197 recipients with HIV (HIV R+) vs 34,213 without HIV (HIV R-) and used nonparametric tests of trend and Gini coefficients to quantify changes over time. Adjusted Cox regression, stratified by transplant centers, and modified Poisson regression were used to compare transplant outcomes in HIV R+ vs HIV R-. Results: Annual HIV R+ HT increased from 0.3% in 2014 to 0.9% of HTs in 2024 ( Conclusions: The practice of HT in PWH has expanded over time, though it is still clustered, occurring at 72 limited number of programs. Patient survival and rejection among HIV R+ are comparable to HIV R-.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.